PUB - Publikationen an der Universität Bielefeld

Hoffmann, L., Coras, R., Kobow, K., Lopez-Rivera, J. A., Lal, D., Leu, C., Najm, I., et al. (2023). Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02577-x

Hoffmann, L., Coras, R., Kobow, K., Lopez-Rivera, J. A., Lal, D., Leu, C., Najm, I., Nürnberg, P., Herms, J., Harter, P. N., et al. (2023). Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathologica.

Hoffmann, L., et al., 2023. Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathologica.

L. Hoffmann, et al., “Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes”, Acta Neuropathologica, 2023.

Hoffmann, L., Coras, R., Kobow, K., Lopez-Rivera, J.A., Lal, D., Leu, C., Najm, I., Nürnberg, P., Herms, J., Harter, P.N., Bien, C., Kalbhenn, T., Müller, M., Pieper, T., Hartlieb, T., Kudernatsch, M., Hamer, H., Brandner, S., Rössler, K., Blümcke, I., Jabari, S.: Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathologica. (2023).

Hoffmann, Lucas, Coras, Roland, Kobow, Katja, Lopez-Rivera, Javier A, Lal, Dennis, Leu, Costin, Najm, Imad, Nürnberg, Peter, Herms, Jochen, Harter, Patrick N, Bien, Christian, Kalbhenn, Thilo, Müller, Markus, Pieper, Tom, Hartlieb, Till, Kudernatsch, Manfred, Hamer, Hajo, Brandner, Sebastian, Rössler, Karl, Blümcke, Ingmar, and Jabari, Samir. “Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes”. Acta Neuropathologica (2023).